<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02386852</url>
  </required_header>
  <id_info>
    <org_study_id>Sunway-979</org_study_id>
    <nct_id>NCT02386852</nct_id>
  </id_info>
  <brief_title>Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity</brief_title>
  <official_title>Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunway University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunway University</source>
  <brief_summary>
    <textblock>
      There is some evidence to suggest that ginseng and Ginkgo biloba can improve cognitive
      performance, however, very little is known about the mechanisms associated with such
      improvement. Here, we tested whether cardiovascular reactivity to a task is associated with
      cognitive improvement.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive performance as modulated by either ginseng or ginkgo biloba</measure>
    <time_frame>Acute effects (3 days of testing)</time_frame>
    <description>Cognitive effects on tests of vigilance/attention, behavioural flexibility and executive functioning</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular reactivity as a result of ginseng or ginkgo biloba intake</measure>
    <time_frame>Acute effects (3 days of testing)</time_frame>
    <description>Changes in systolic, diastolic and heart rate reading as a result of ginseng or ginkgo biloba intake and dependent upon the type of cognitive domain assessed (i.e. vigilance, behavioural flexibility or executive functioning.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Cognition</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study subjects received, in a double blind fashion, placebo pills identical to the drug (ginseng: group 1; ginkgo biloba: group 2).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ginseng</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the ginseng group received a medium, and higher dose of ginseng in addition to placebo capsules.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ginkgo Biloba</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the ginkgo biloba group received a medium, and higher dose of ginkgo in addition to placebo capsules.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Study subjects received, in a double blind fashion, placebo pills identical to the drug (drug 1-ginseng, group 1; drug 2-ginkgo biloba-group 2)</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Ginseng</arm_group_label>
    <arm_group_label>Ginkgo Biloba</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginseng</intervention_name>
    <description>The ginseng group received two capsules containing either 1000 mg or 500 mg of Panax Ginseng extract standardized to 3% of ginsenosides (GNC, USA) or similarly looking placebo capsules over a period of three days of testing.</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Ginseng</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginkgo Biloba</intervention_name>
    <description>The ginkgo group received two capsules containing either 240 mg or 120 mg of ginkgo biloba extract standardized to 24% ginkgo flavone glycosides and 6% terpene lactones (GBE24/6) or similarly looking placebo capsules over a period of three testing days.</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Ginkgo Biloba</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers ranging in age between 18 and 30.

        Exclusion Criteria:

          -  Ginseng group: exclude those that regularly consume caffeine or Panax Ginseng, or
             those that are diabetic, have hormone sensitive conditions, autoimmune diseases,
             bleeding conditions, heart conditions or take medications that are known to interact
             with Panax Ginseng. These include anticoagulants, Warfarin, Ibuprofen, MAOIs,
             medications that are changed by the liver, and stimulant drugs (e.g. pseudoephedrine,
             epinephrine).

          -  Ginkgo Biloba group: exclude those that regularly consume caffeine or Ginkgo Biloba,
             or those that are diabetic, have experienced seizures in the past, have bleeding
             disorders, or take medications that are known to interact with Ginkgo Biloba. These
             include Ibuprofen, anticoagulants, Warfarin, Buspirone, Fluoxetine, Trazodone
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luca Aquili, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunway University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychology, Sunway University</name>
      <address>
        <city>Bandar Sunway</city>
        <state>Selangor</state>
        <zip>47500</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2015</study_first_submitted>
  <study_first_submitted_qc>March 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2015</study_first_posted>
  <last_update_submitted>March 11, 2015</last_update_submitted>
  <last_update_submitted_qc>March 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sunway University</investigator_affiliation>
    <investigator_full_name>Dr. Luca Aquili</investigator_full_name>
    <investigator_title>Dr. Luca Aquili</investigator_title>
  </responsible_party>
  <keyword>Ginseng</keyword>
  <keyword>Ginkgo Biloba</keyword>
  <keyword>cardiovascular reactivity</keyword>
  <keyword>cognition</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

